Key Whitman Eye Center — research payments reported

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$30,082	15
2024	Research	$5,881	2
2023	Research	$22,429	4
2022	Research	$33,734	48
2021	Research	$185,483	233
2020	Research	$81,214	100
2019	Research	$20,793	18

Breakdown

Who paid Research payments · program years 2019–2025

Alcon Research LLC $283,650 367 payments
Bausch Health US, LLC $50,730 20 payments
Bausch & Lomb Americas Inc. $32,428 5 payments
Allergan Inc. $6,928 26 payments
RxSight Inc $5,881 2 payments

Studies the money was for Research payments · program years 2019–2025

Pivotal Trial of WaveLight EX500 Excimer Laser System for the Correction of Myopia with and without Astigmatism Using InnovEyes in Conjunction with InnovEyes sightmap $253,568 352 payments
A Prospective, Multicenter, Randomized, Active-Controlled Clinical Study to Evaluate the Safety and Effectiveness of the Envista One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction $65,381 14 payments
Astigmatic Blur Study of Clareon Vivity $30,082 15 payments
A Prospective, Post Approval Study to Evaluate the Trulign Toric Posterior Chamber Intraocular Lens Iol $10,138 4 payments
A Prospective Multicenter, Randomized, Active-Controlled, Masked Clinical Study to Evaluate the Safety and Effectiveness of the Envista One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction $7,639 7 payments
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $5,881 2 payments
Efficacy and Safety of Bimatoprost Sustained-Release Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension $3,017 7 payments
An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension $2,486 15 payments
Efficacy and Safety of Bimatoprost Sustained-Release (Sr) in Patients With Open-Angle Glaucoma Or Ocular Hypertension $1,425 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.